Mylan Says Allergan Misusing Tribal Sovereignty in Patent Dispute Mylan Says Allergan Misusing Tribal Sovereignty in Patent Dispute

Generic drugmaker Mylan NV alleged in a court filing that rival Allergan Plc is trying to take advantage of Native American sovereignty to shield its patent for the blockbuster dry-eye treatment Restasis.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news